Annual Total Long Term Liabilities
$9.27 M
-$25.76 M-73.53%
31 December 2023
Summary:
Aclaris Therapeutics annual total long term liabilities is currently $9.27 million, with the most recent change of -$25.76 million (-73.53%) on 31 December 2023. During the last 3 years, it has fallen by -$8.99 million (-49.21%). ACRS annual total long term liabilities is now -74.72% below its all-time high of $36.68 million, reached on 31 December 2014.ACRS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$33.43 M
+$21.86 M+188.99%
30 September 2024
Summary:
Aclaris Therapeutics quarterly total long term liabilities is currently $33.43 million, with the most recent change of +$21.86 million (+188.99%) on 30 September 2024. Over the past year, it has dropped by -$1.27 million (-3.67%). ACRS quarterly long term liabilities is now -57.31% below its all-time high of $78.31 million, reached on 30 September 2015.ACRS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.5% | -3.7% |
| 3 y3 years | -49.2% | +15.0% |
| 5 y5 years | -72.0% | -7.5% |
ACRS Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -73.5% | at low | -4.6% | +260.4% |
| 5 y | 5 years | -73.5% | +55.8% | -15.0% | +461.5% |
| alltime | all time | -74.7% | -57.3% |
Aclaris Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $33.43 M(+189.0%) |
| June 2024 | - | $11.57 M(-3.4%) |
| Mar 2024 | - | $11.97 M(+29.1%) |
| Dec 2023 | $9.27 M(-73.5%) | $9.27 M(-73.3%) |
| Sept 2023 | - | $34.70 M(+4.9%) |
| June 2023 | - | $33.07 M(-4.5%) |
| Mar 2023 | - | $34.64 M(-1.1%) |
| Dec 2022 | $35.04 M(+13.2%) | $35.04 M(+25.1%) |
| Sept 2022 | - | $28.00 M(+7.7%) |
| June 2022 | - | $26.01 M(-12.1%) |
| Mar 2022 | - | $29.60 M(-4.3%) |
| Dec 2021 | $30.94 M(+69.4%) | $30.94 M(+6.4%) |
| Sept 2021 | - | $29.07 M(-26.0%) |
| June 2021 | - | $39.31 M(+13.6%) |
| Mar 2021 | - | $34.60 M(+89.5%) |
| Dec 2020 | $18.26 M(+206.7%) | $18.26 M(-0.5%) |
| Sept 2020 | - | $18.36 M(+2.6%) |
| June 2020 | - | $17.89 M(-0.8%) |
| Mar 2020 | - | $18.03 M(+202.9%) |
| Dec 2019 | $5.95 M | $5.95 M(-83.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $36.15 M(-3.0%) |
| June 2019 | - | $37.26 M(+7.4%) |
| Mar 2019 | - | $34.70 M(+4.8%) |
| Dec 2018 | $33.10 M(+503.5%) | $33.10 M(+337.4%) |
| Sept 2018 | - | $7.57 M(+0.3%) |
| June 2018 | - | $7.55 M(+19.3%) |
| Mar 2018 | - | $6.33 M(+15.4%) |
| Dec 2017 | $5.49 M(+1374.5%) | $5.49 M(-23.2%) |
| Sept 2017 | - | $7.14 M(+2320.0%) |
| June 2017 | - | $295.00 K(+3.9%) |
| Mar 2017 | - | $284.00 K(-23.7%) |
| Dec 2016 | $372.00 K(>+9900.0%) | $372.00 K(+3.9%) |
| Sept 2016 | - | $358.00 K(+3.8%) |
| June 2016 | - | $345.00 K(+4.5%) |
| Mar 2016 | - | $330.00 K(>+9900.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2015 | - | $78.31 M(>+9900.0%) |
| June 2015 | - | $3000.00(-100.0%) |
| Dec 2014 | $36.68 M(+59.5%) | $36.68 M |
| Dec 2013 | $23.00 M | - |
FAQ
- What is Aclaris Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual total long term liabilities year-on-year change?
- What is Aclaris Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly long term liabilities year-on-year change?
What is Aclaris Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ACRS is $9.27 M
What is the all time high annual total long term liabilities for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual total long term liabilities is $36.68 M
What is Aclaris Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ACRS annual total long term liabilities has changed by -$25.76 M (-73.53%)
What is Aclaris Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ACRS is $33.43 M
What is the all time high quarterly long term liabilities for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly total long term liabilities is $78.31 M
What is Aclaris Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ACRS quarterly total long term liabilities has changed by -$1.27 M (-3.67%)